Jill C. Keach
Mayo Clinic · 48 works · 8,481 citations · h-index 26
Top works
- Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis #
- Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis
- Elevated Serum IgG4 Concentration in Patients with Primary Sclerosing Cholangitis
- Betaine for nonalcoholic fatty liver disease
- Alendronate Improves Bone Mineral Density in Primary Biliary Cirrhosis: A Randomized Placebo-Controlled Trial * #
- Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid
- Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis ‐ a pilot study
- Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid
- Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system
- Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not Have Cholangiocarcinoma
- Bone Disease in Patients With Primary Sclerosing Cholangitis
- Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH)
- Bile Acid Changes After High-Dose Ursodeoxycholic Acid Treatment in Primary Sclerosing Cholangitis: Relation to Disease Progression
- Minocycline in the Treatment of Patients With Primary Sclerosing Cholangitis: Results of a Pilot Study
- Tacrolimus for the treatment of primary sclerosing cholangitis
- High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis
- Mycophenolate Mofetil for the Treatment of Primary Sclerosing Cholangitis
- High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis